83 related articles for article (PubMed ID: 15389798)
1. Access of tumor-derived macromolecules and cells to the blood: an electron microscopical study of structural barriers in microvessel clusters in highly malignant primary prostate carcinomas.
Wieser E; Strohmeyer D; Rogatsch H; Horninger W; Bartsch G; Debbage P
Prostate; 2005 Feb; 62(2):123-32. PubMed ID: 15389798
[TBL] [Abstract][Full Text] [Related]
2. Pericyte coverage decreases invasion of tumour cells into blood vessels in prostate cancer xenografts.
Welén K; Jennbacken K; Tesan T; Damber JE
Prostate Cancer Prostatic Dis; 2009; 12(1):41-6. PubMed ID: 18521102
[TBL] [Abstract][Full Text] [Related]
3. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
Man YG; Gardner WA
Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
[TBL] [Abstract][Full Text] [Related]
4. Computerized whole slide quantification shows increased microvascular density in pT2 prostate cancer as compared to normal prostate tissue.
van Niekerk CG; van der Laak JA; Börger ME; Huisman HJ; Witjes JA; Barentsz JO; Hulsbergen-van de Kaa CA
Prostate; 2009 Jan; 69(1):62-9. PubMed ID: 18780292
[TBL] [Abstract][Full Text] [Related]
5. Analysis of microvessels in pancreatic cancer: by light microscopy, confocal laser scan microscopy, and electron microscopy.
Takagi K; Takada T; Amano H; Yoshida M; Miura H; Toyota N; Wada K; Takahashi I
J Hepatobiliary Pancreat Surg; 2008; 15(4):384-90. PubMed ID: 18670839
[TBL] [Abstract][Full Text] [Related]
6. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma.
Riesenberg R; Weiler C; Spring O; Eder M; Buchner A; Popp T; Castro M; Kammerer R; Takikawa O; Hatz RA; Stief CG; Hofstetter A; Zimmermann W
Clin Cancer Res; 2007 Dec; 13(23):6993-7002. PubMed ID: 18056175
[TBL] [Abstract][Full Text] [Related]
7. Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis.
Yang G; Addai J; Wheeler TM; Frolov A; Miles BJ; Kadmon D; Thompson TC
Hum Pathol; 2007 Nov; 38(11):1688-95. PubMed ID: 17707459
[TBL] [Abstract][Full Text] [Related]
8. Increased expressions of vascular endothelial growth factor (VEGF), VEGF-C and VEGF receptor-3 in prostate cancer tissue are associated with tumor progression.
Yang J; Wu HF; Qian LX; Zhang W; Hua LX; Yu ML; Wang Z; Xu ZQ; Sui YG; Wang XR
Asian J Androl; 2006 Mar; 8(2):169-75. PubMed ID: 16491267
[TBL] [Abstract][Full Text] [Related]
9. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
10. The expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and angiogenesis markers in hyperplastic and malignant prostate tissue.
Lekas A; Lazaris AC; Deliveliotis C; Chrisofos M; Zoubouli C; Lapas D; Papathomas T; Fokitis I; Nakopoulou L
Anticancer Res; 2006; 26(4B):2989-93. PubMed ID: 16886625
[TBL] [Abstract][Full Text] [Related]
11. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
Zhao J; Epstein JI
Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
[TBL] [Abstract][Full Text] [Related]
12. Imaging glioma cell invasion in vivo reveals mechanisms of dissemination and peritumoral angiogenesis.
Winkler F; Kienast Y; Fuhrmann M; Von Baumgarten L; Burgold S; Mitteregger G; Kretzschmar H; Herms J
Glia; 2009 Sep; 57(12):1306-15. PubMed ID: 19191326
[TBL] [Abstract][Full Text] [Related]
13. Novel three-dimensional organotypic liver bioreactor to directly visualize early events in metastatic progression.
Yates C; Shepard CR; Papworth G; Dash A; Beer Stolz D; Tannenbaum S; Griffith L; Wells A
Adv Cancer Res; 2007; 97():225-46. PubMed ID: 17419948
[TBL] [Abstract][Full Text] [Related]
14. Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer.
Gravdal K; Halvorsen OJ; Haukaas SA; Akslen LA
Cancer Res; 2009 Jun; 69(11):4708-15. PubMed ID: 19487287
[TBL] [Abstract][Full Text] [Related]
15. Critical and opposing roles of the chemokine receptors CXCR2 and CXCR3 in prostate tumor growth.
Shen H; Schuster R; Lu B; Waltz SE; Lentsch AB
Prostate; 2006 Dec; 66(16):1721-8. PubMed ID: 16941672
[TBL] [Abstract][Full Text] [Related]
16. Ossifying fibromyxoid tumor: modified myoepithelial cell tumor? Report of three cases with immunohistochemical and electron microscopic studies.
Min KW; Seo IS; Pitha J
Ultrastruct Pathol; 2005; 29(6):535-48. PubMed ID: 16316954
[TBL] [Abstract][Full Text] [Related]
17. Microvessel organization and structure in experimental brain tumors: microvessel populations with distinctive structural and functional properties.
Schlageter KE; Molnar P; Lapin GD; Groothuis DR
Microvasc Res; 1999 Nov; 58(3):312-28. PubMed ID: 10527772
[TBL] [Abstract][Full Text] [Related]
18. Role of human cripto-1 in tumor angiogenesis.
Bianco C; Strizzi L; Ebert A; Chang C; Rehman A; Normanno N; Guedez L; Salloum R; Ginsburg E; Sun Y; Khan N; Hirota M; Wallace-Jones B; Wechselberger C; Vonderhaar BK; Tosato G; Stetler-Stevenson WG; Sanicola M; Salomon DS
J Natl Cancer Inst; 2005 Jan; 97(2):132-41. PubMed ID: 15657343
[TBL] [Abstract][Full Text] [Related]
19. Analysis of interleukin (IL)-8 expression in human astrocytomas: associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry.
Samaras V; Piperi C; Levidou G; Zisakis A; Kavantzas N; Themistocleous MS; Boviatsis EI; Barbatis C; Lea RW; Kalofoutis A; Korkolopoulou P
Hum Immunol; 2009 Jun; 70(6):391-7. PubMed ID: 19332096
[TBL] [Abstract][Full Text] [Related]
20. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]